Patents by Inventor Maria Julia LARA

Maria Julia LARA has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240150735
    Abstract: Provided herein are recombinant polymerases that are suitable for nucleic acid amplification assays. The recombinant polymerases disclosed herein are useful in many recombinant DNA techniques, in particular nucleic acid amplification. Also provided herein are methods of producing the recombinant polymerases.
    Type: Application
    Filed: June 21, 2022
    Publication date: May 9, 2024
    Inventors: Guillermo Daniel REPIZO, Maria Julia LARA, Carla Alejandra GIMENEZ, Antonela Rocio PALACIOS, Alejandro PEZZA, Ivana Lorna PARCERISA, Matias Ezequiel CABRUJA
  • Publication number: 20230072431
    Abstract: Provided herein are novel Class 2 Type II, Type V, type VI CRISPR-Cas RNA-guided endonucleases and systems comprising the same. Provided also are methods of making, and methods of use thereof. Exemplary methods of use include modifying target nucleic acids useful for therapeutic applications, and also include detecting targeting nucleic acids, useful for diagnostic applications.
    Type: Application
    Filed: November 3, 2021
    Publication date: March 9, 2023
    Inventors: Carla Alejandra GIMÉNEZ, Maria Julia LARA
  • Publication number: 20220135958
    Abstract: Provided herein are novel Class 2 Type II, Type V, type VI CRISPR-Cas RNA-guided endonucleases and systems comprising the same. Provided also are methods of making, and methods of use thereof. Exemplary methods of use include modifying target nucleic acids useful for therapeutic applications, and also include detecting targeting nucleic acids, useful for diagnostic applications.
    Type: Application
    Filed: December 3, 2021
    Publication date: May 5, 2022
    Inventors: Carla Alejandra GIMÉNEZ, Maria Julia LARA
  • Publication number: 20220136050
    Abstract: Provided herein are novel Class 2 Type II, Type V, type VI CRISPR-Cas RNA-guided endonucleases and systems comprising the same. Provided also are methods of making, and methods of use thereof. Exemplary methods of use include modifying target nucleic acids useful for therapeutic applications, and also include detecting targeting nucleic acids, useful for diagnostic applications.
    Type: Application
    Filed: December 3, 2021
    Publication date: May 5, 2022
    Inventors: Carla Alejandra GIMÉNEZ, Maria Julia LARA